BF
Schedule 13G filing
BJI Financial Group disclosed a 6% stake in Sunshine Biopharma Inc. (SBFM)
BJI Financial Group reported owning 6% of Sunshine Biopharma Inc. (SBFM) (909,900 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.